SPERO THERAPEUTICS INC. - COMMON STOCK

Spero Therapeutics Enters Into a Non-Dilutive Revenue Interest Financing Agreement With HealthCare Royalty Partners® for Up to $125 Million

30 сен 2021 08:00:01 Источник Nasdaq GlobeNewswire

Spero Therapeutics to Present Data at IDWeek 2021

16 сен 2021 08:05:00 Источник Nasdaq GlobeNewswire

Spero Therapeutics to Present at Three Upcoming Investor Conferences

07 сен 2021 08:05:00 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

31 авг 2021 16:25:43 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces Second Quarter 2021 Operating Results and Provides Business Update

05 авг 2021 16:01:01 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30 июл 2021 16:33:29 Источник Nasdaq GlobeNewswire

Spero Therapeutics to Provide Business Update and Report Second Quarter 2021 Financial Results on Thursday, August 5, 2021

29 июл 2021 16:01:00 Источник Nasdaq GlobeNewswire

Spero Therapeutics to Present at the Ladenburg Thalmann Healthcare Conference

07 июл 2021 16:01:00 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

02 июл 2021 16:01:00 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces $40 Million Equity Investment from Pfizer Inc. and Licensing Agreement for SPR206

30 июн 2021 18:46:29 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces the Initiation of Bronchoalveolar Lavage and Renal Impairment Clinical Trials of SPR206

15 июн 2021 16:01:00 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

28 май 2021 17:35:49 Источник Nasdaq GlobeNewswire

Spero Therapeutics Awarded up to $23 Million by the National Institute of Allergy and Infectious Diseases to Support the Development of SPR206

17 май 2021 16:01:00 Источник Nasdaq GlobeNewswire

Spero Therapeutics to Participate at the Berenberg Conference USA

13 май 2021 08:00:01 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces First Quarter 2021 Operating Results and Provides Business Update

06 май 2021 16:01:01 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

30 апр 2021 16:26:03 Источник Nasdaq GlobeNewswire

Spero Therapeutics to Provide Business Update and Report First Quarter 2021 Financial Results on Thursday, May 6, 2021

29 апр 2021 16:01:00 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

31 мар 2021 16:31:39 Источник Nasdaq GlobeNewswire

Spero Therapeutics Announces Fourth Quarter and Full-Year 2020 Operating Results and Provides Business Update

11 мар 2021 16:07:00 Источник Nasdaq GlobeNewswire

Spero Therapeutics to Provide Business Update and Report Fourth Quarter and Full-Year 2020 Financial Results on Thursday, March 11, 2021

03 мар 2021 08:30:00 Источник Nasdaq GlobeNewswire